البحث | Pikumil

Nilesh Prajapati أضاف وظيفة جديدة أخرى
2026-06-04 14:42:54 -

Market Drivers and Challenges in the mTOR Inhibitors Sector 2034
The growing focus on targeted therapies is transforming the treatment landscape for several chronic and life-threatening diseases. Advances in molecular biology and precision medicine have accelerated the adoption of therapies that target specific cellular pathways, improving treatment outcomes and patient management. Increasing investments in oncology research, expanding clinical applications,...

0 التعليقات 0 المشاركات 486 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Dbmr Market أضاف وظيفة جديدة أخرى
2026-04-29 14:37:26 -

mTOR Inhibitors Market: Targeted Therapies in Oncology and Transplantation
Mechanistic Target of Rapamycin (mTOR) Inhibitors Market Summary: According to the latest report published by Data Bridge Market Research, the Mechanistic Target of Rapamycin (mTOR) Inhibitors Market CAGR Value The global Mechanistic Target of Rapamycin (mTOR) Inhibitors market size was valued at USD 7.74 billion in 2025 and is expected to reach USD 10.19 billion...

0 التعليقات 0 المشاركات 293 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Nikita Girmal أضاف وظيفة جديدة أخرى
2026-01-09 10:25:20 -

Tuberous Sclerosis Drug Market Size Projected to Reach USD 1,560.56 Million by 2032
“According to a new report published by Introspective Market Research, Tuberous Sclerosis Drug Market by Drug Type, Indication, and Distribution Channel, The Global Tuberous Sclerosis Drug Market Size Was Valued at USD 831.20 Million in 2023 and is Projected to Reach USD 1,560.56 Million by 2032, Growing at a CAGR of 7.25% From 2024–2032.” The Tuberous Sclerosis Drug Market...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!